Current Enterprise Value (EV)
Current share price (P) | $637.36 |
No. shares of common stock outstanding | 109,324,682 |
US$ in thousands | |
Common equity (market value)1 | 69,679,179) |
Add: Preferred Stock, par value $.01 per share; issued and outstanding: none (per books) | —) |
Total equity | 69,679,179) |
Add: Finance lease liabilities, current portion (per books) | —) |
Add: Long-term debt (per books) | 1,984,400) |
Add: Finance lease liabilities, excluding current portion (per books) | 720,000) |
Total equity and debt | 72,383,579) |
Less: Cash and cash equivalents | 2,488,200) |
Less: Marketable securities | 6,524,300) |
Enterprise value (EV) | 63,371,079) |
Based on: 10-K (reporting date: 2024-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 637.36 × 109,324,682
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Regeneron Pharmaceuticals Inc. Annual Report.
3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 716.72 × 109,324,682
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Regeneron Pharmaceuticals Inc. EV increased from 2022 to 2023 but then decreased significantly from 2023 to 2024. |